List of 29 covariates selected from a list of 71 variables using recursive feature elimination and further selection of 17 uncorrelated covariates (shaded grey). by Dennis Ochola (11626912)

Decreased eIF2B GEF activity in eIF2B-mutated patients' lymphoblasts (LLB). by Laetitia Horzinski (156394)

Impairment of IL-2 responses correlate with lower CD25 expression and decreased IL-7 responses. by Florence Bugault (278171)

Mutation of Ser-489 in GC-B to alanine but not glutamate decreases CNP-stimulated guanylyl cyclase activity. by Andrea R. Yoder (165684)

Subgroup analyses of the association between decreases in serum UA levels and poor functional outcome at 3 months. by Kuniyuki Nakamura (13040299)

“…<p>The ORs and 95% CIs of poor functional outcome (defined as an mRS score of 3–6 at 3 months) are shown according to UA decrease rate grade (G1 to G4) in each subgroup. The subgroups included (<b>A</b>) age (<75 or ≥75 years), (<b>B</b>) sex (women or men), (<b>C</b>) stroke subtype (non-cardioembolic or cardioembolic), (<b>D</b>) neurological severity (NIHSS <5 or ≥5), (<b>E</b>) CKD (presence or absence), and (<b>F</b>) UA level on admission (<292 or ≥292 μmol/L for women, <351 or ≥351 μmol/L for men). …”

The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution. by Pia Steensland (362091)

“…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”

SFN decreases immunosuppressive MDSC formation in response to GCM but increases CD14-/HLA-DR+ cells. by Ravi Kumar (188257)

CTGF immunoreactivity is decreased and CTGF mRNA is down-regulated in co-cultures of GBM cells with neurons. by Luciana F. Romão (278706)

“…Bar 50 µm. Densitometry of the immunocytochemistry images show a decrease in the intensity of CTGF staining of GBM95, GBM02 or U87 co-cultured with P0 neurons (J–L) (p<0.05). …”

Co-ablation of p53 decreases apoptosis and the survival of Dicer^Δ/Δ mice. by Stephen Lyle (365801)

“…<p><b>A</b>) Hematoxylin and eosin staining of skin tissue sections of 5-month old mice. Control (K5-Cre+ transgene) was similar in appearance to wildtype control samples, whereas ablation of <i>Dicer</i> showed reduced and misshapen follicle morphology, with increased epithelial thickening, mitotic figures (arrow), and incidence of apoptosis (arrowheads). …”

Inhibition of NM-2 activity through drug treatments produces decreased FM1-43 internalization. by Juan A. Flores (587973)

Tacrolimus decreased SFRP2 induced nuclear NFATc3 in 2H11 endothelial cells. by Sharareh Siamakpour-Reihani (218652)

Inhibition of NM-2 activity through drug treatments produces decreased FM1-43 internalization. by Juan A. Flores (587973)

H-NST mutants exhibit decreased ability to induce the production of <i>LEE</i>-encoded proteins. by Jonathan A. Levine (512013)

Comparison of VO₂ max (ml/kg/min) between the DM and HC. by Uzair Abbas (18517982)

Ablation of Tph1 gene in dams decreased circulating serotonin and calcium on day 1 and 10 of lactation. by Jimena Laporta (383836)

Prenatal immune challenge decreases the frequency and amplitude of miniIPSCs recorded in CA1 pyramidal cells. by Guillaume Ducharme (335842)

The N15D mutation, but not the N71D mutation, decreases the thermal stability of HsTIM. by Ignacio de la Mora-de la Mora (435666)

Decrease in hepatic SMP30 levels in <i>Lepr^db/db</i> mice. by Yoshitaka Kondo (417812)

The NK1-receptor antagonist ezlopitant significantly and selectively decreases voluntary intake of both sucrose and ethanol. by Pia Steensland (362091)

“…<p>Ezlopitant decreased consumption of 5% sucrose (<b>A</b>), whereas only the highest dose of ezlopitant (10 mg/kg) decreased consumption of 20% ethanol (<b>B</b>). …”

Cre-mediated activation of RIαB allele specifically in the liver decreases PKA activity in vivo. by Brandon S. Willis (353418)